DexComDXCM
NASDAQ · USA · Segment 1 of 8 in the Medicine, pharma & life science value chain: Diabetes & metabolic disease
Continuous glucose monitoring for people with diabetes: the G-series sensors, and Stelo, which is sold over the counter.
Diabetes & metabolic disease: Treatment and monitoring of diabetes and metabolic disease, from insulin to glucose monitoring.
Key metrics
Market cap
$34.5B
Price
$91.06
Today
−1.4%
Return YTD
+39.1%
Return 1Y
+14.5%
P/E
34.5
P/S
6.9
P/B
13.2
Data as of 2026-08-25 · updates daily after U.S. close
Theme exposure
In the value chain
Supply chain
Supplies →
Same segment: Diabetes & metabolic disease
Compare DXCM
See where DexCom sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →